Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease
Research in the last decades has demonstrated the relevance of epigenetics in controlling gene expression to maintain cell homeostasis, and the important role played by epigenome alterations in disease development. Moreover, the reversibility of epigenetic marks can be harnessed as a therapeutic str...
Main Authors: | María Arechederra, Miriam Recalde, María Gárate-Rascón, Maite G. Fernández-Barrena, Matías A. Ávila, Carmen Berasain |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/6/1265 |
Similar Items
-
Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?
by: Alex Claveria-Cabello, et al.
Published: (2020-10-01) -
Epigenetic remodelling in human hepatocellular carcinoma
by: Maria Rita Braghini, et al.
Published: (2022-03-01) -
Cancer Treatment: An Epigenetic View
by: Cansu Aydin, et al.
Published: (2020-06-01) -
Epigenetics in hepatocellular carcinoma development and therapy: The tip of the icebergKey points
by: Maite G. Fernández-Barrena, et al.
Published: (2020-12-01) -
DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis
by: Miriam Recalde, et al.
Published: (2022-04-01)